Colocado no site suzana gontijo preprint fran



Baixar 142.05 Kb.
Página36/36
Encontro21.08.2021
Tamanho142.05 Kb.
#16855
1   ...   28   29   30   31   32   33   34   35   36
INFORMAÇÃO DOS AUTORES

Nascimento CM: http://orcid.org/0000-0001-5834-4381

Machado AM: http://orcid.org/0000-0002-9490-3221

Guerra JC: http://orcid.org/0000-0002-4156-529X

Zlotnik E: http://orcid.org/0000-0002-6137-9259

Campêlo DH: http://orcid.org/0000-0001-9392-2124

Kauffman P: http://orcid.org/0000-0002-4363-4148

Waksman H: http://orcid.org/0000-0002-1509-5212

Wolosker N: http://orcid.org/0000-0003-1991-3507

Podgaec S: http://orcid.org/0000-0002-9760-6003

Hamerschlak N: http://orcid.org/0000-0002-5140-5310

REFERÊNCIAS

1. Middeldorp S. Inherited thrombophilia: a double-edged sword. Hematology (Am Soc Hematol Educ Program). 2016;2016(1):1-9. 

2. James AH, Jamison MG, Brancazio LR, Myers ER. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol. 2006;194(5):1311-5

3. Meng K, Hu X, Peng X, Zhang Z. Incidence of venous thromboembolism during pregnancy and the puerperium: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2015;28(3):245-53. 

4. Kourlaba G, Relakis J, Kontodimas S, Holm MV, Maniadakis N. A systematic review and meta-analysis of the epidemiology and burden of venous thromboembolism among pregnant women. Int J Gynaecol Obstet. 2016;132(1):4-10. 

5. Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol. 2015; 12(8):464-74. 

6. Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e691S-736S.

7. Moll S. Thrombophilia: clinical-practical aspects. J Thromb Thrombolysis. 2015 ;39(3):367-78. 

8. Stevens SM, Woller SC, Bauer KA, Kasthuri R, Cushman M, Streiff M, et al. Guidance for the evaluation and treatment of hereditary and acquired thrombophilia. J Thromb Thrombolysis. 2016 Jan;41(1):154-64. 

9. Wu O, Greer IA. Is screening for thrombophilia cost-effective? Curr Opin Hematol. 2007;14(5):500-3. 

10. Connors JM. Thrombophilia Testing and Venous Thrombosis. N Engl J Med. 2017 ;377(12):1177-87. 

11. Hicks LK, Bering H, Carson KR, Haynes AE, Kleinerman J, Kukreti V, et al. Five hematologic tests and treatments to question. Blood. 2014;124(24):3524-8. 

12. Baglin T, Gray E, Greaves M, Hunt BJ, Keeling D, Machin S, et al.; British Committee for Standards in Haematology. Clinical guidelines for testing for heritable thrombophilia. Br J Haematol. 2010;149(2):209-20. 

13. Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss. Fertil Steril. 2008;89(6):1603. 

14. Ray JG, Chan WS. Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation. Obstet Gynecol Surv. 1999;54(4):265-71. 

15. Sørensen HT, Riis AH, Diaz LJ, Andersen EW, Baron JA, Andersen PK. Familial risk of venous thromboembolism: a nationwide cohort study. J Thromb Haemost. 2011 ;9(2):320-4. 

16. Kurasawa G, Kotani K, Ito Y, Saiga K, Iijima K. Reduction in protein S activity during normal pregnancy. Aust N Z J Obstet Gynaecol. 2007;47(3):213-5. 

17. Jennings I, Kitchen S, Woods TA, Preston FE. Multilaboratory testing in thrombophilia through the United Kingdom National External Quality Assessment Scheme (Blood Coagulation) Quality Assurance Program. Semin Thromb Hemost. 2005 ;31(1):66-72. 

18. van Hylckama Vlieg A, Helmerhorst FM, Vandenbroucke JP, Doggen CJ, Rosendaal FR. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ. 2009;339:b2921. 

19. Lidegaard Ø, Nielsen LH, Skovlund CW, Skjeldestad FE, Løkkegaard E. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: danish cohort study, 2001-9. BMJ. 2011;343:d6423.

20. Canonico M, Oger E, Plu-Bureau G, Conard J, Meyer G, Lévesque H, et al.; Estrogen and Thromboembolism Risk (ESTHER) Study Group. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation. 2007;115(7):840-5.

21. Lidegaard Ø, Løkkegaard E, Svendsen AL, Agger C. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ. 2009;339:b2890. 

22. de Bastos M, Stegeman BH, Rosendaal FR, Van Hylckama Vlieg A, Helmerhorst FM, Stijnen T, et al. Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Rev. 2014;(3):CD010813. 

23. van Hylckama Vlieg A, Middeldorp S. Hormone therapies and venous thromboembolism: where are we now? J Thromb Haemost. 2011;9(2):257-66.

24. L’Hermite M. HRT optimization, using transdermal estradiol plus micronized progesterone, a safer HRT. Climacteric. 2013;16(sup1 Suppl 1):44-53. 

25. Vieira CS, Ferriani RA, Garcia AA, Pintão MC, Azevedo GD, Gomes MK, et al. Use of the etonogestrel-releasing implant is associated with hypoactivation of the coagulation cascade. Hum Reprod. 2007;22(8):2196-201. 

26. Roumen FJ, Mishell DR Jr. The contraceptive vaginal ring, NuvaRing(®), a decade after its introduction. Eur J Contracept Reprod Health Care. 2012;17(6):415-27. 

27. van Hylckama Vlieg A, Helmerhorst FM, Rosendaal FR. The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device. Arterioscler Thromb Vasc Biol. 2010;30(11):2297-300. 

28. Ruffatti A, Salvan E, Del Ross T, Gerosa M, Andreoli L, Maina A, et al. Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study. Thromb Haemost. 2014;112(4):727-35. 

29. Santos TD, Ieque AL, de Carvalho HC, Sell AM, Lonardoni MV, Demarchi IG, et al. Antiphospholipid syndrome and recurrent miscarriage: A systematic review and meta-analysis. J Reprod Immunol. 2017;123:78-87. 

30. Working Party; Association of Anaesthetists of Great Britain & Ireland; Obstetric Anaesthetists’ Association; Regional Anaesthesia UK. Regional anaesthesia and patients with abnormalities of coagulation: the Association of Anaesthetists of Great Britain & Ireland The Obstetric Anaesthetists’ Association Regional Anaesthesia UK. Anaesthesia. 2013;68(9):966-72. Erratum in: Anaesthesia. 2016;71(3):352.


Material suplementar:

(links das apresentações)

https://www.einstein.br/Documentos%20Compartilhados/CasosCl%C3%ADnicosemTrombofiliaDraClaudiaMacDonaldBley.pdf

https://www.einstein.br/Documentos%20Compartilhados/DeclaracoesdeConsensoDrJoaoCarlosdeCamposGuerra.pdf



https://www.einstein.br/Documentos%20Compartilhados/TrombofiliadoencaoumodaDrNelsonHamerschlak.pdf

Baixar 142.05 Kb.

Compartilhe com seus amigos:
1   ...   28   29   30   31   32   33   34   35   36




©historiapt.info 2022
enviar mensagem

    Página principal